Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Influenza

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 213 articles:
HTML format



Single Articles


    April 2025
  1. BONTORIN S, Centellegher S, Gallotti R, Pappalardo L, et al
    Mixing individual and collective behaviors to predict out-of-routine mobility.
    Proc Natl Acad Sci U S A. 2025;122:e2414848122.
    PubMed     Abstract available


  2. HUANG QJ, Kim R, Song K, Grigorieff N, et al
    Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryoelectron tomography.
    Proc Natl Acad Sci U S A. 2025;122:e2426427122.
    PubMed     Abstract available


  3. RIOS CARRASCO M, Lin TH, Zhu X, Gabarroca Garcia A, et al
    The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
    Proc Natl Acad Sci U S A. 2025;122:e2419800122.
    PubMed     Abstract available


  4. LIU X, Balligand T, Le Gall C, Ploegh HL, et al
    A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses.
    Proc Natl Acad Sci U S A. 2025;122:e2424889122.
    PubMed     Abstract available


  5. GUAY B, Marghetis T, Wong C, Landy D, et al
    Quirks of cognition explain why we dramatically overestimate the size of minority groups.
    Proc Natl Acad Sci U S A. 2025;122:e2413064122.
    PubMed     Abstract available


    March 2025
  6. GAILLETON R, Mathew NR, Reusch L, Schon K, et al
    Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2421724122.
    PubMed     Abstract available


  7. EILERSEN A, Bjornstad ON, Li R, Schreiber SJ, et al
    Epidemic evolutionarily stable strategies within an age-structured host population.
    Proc Natl Acad Sci U S A. 2025;122:e2418170122.
    PubMed     Abstract available


  8. DOS S P ANDRADE AC, Lacasse E, Dubuc I, Gudimard L, et al
    Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2025;122:e2420441122.
    PubMed     Abstract available


  9. WANG Q, Xu S, Shen W, Wei Y, et al
    N6-methyladnosine of vRNA facilitates influenza A virus replication by promoting the interaction of vRNA with polymerase proteins.
    Proc Natl Acad Sci U S A. 2025;122:e2411554122.
    PubMed     Abstract available


  10. MA Y, Wang J, Cui F, Tang L, et al
    Independent and combined effects of long-term air pollution exposure and genetic predisposition on COVID-19 severity: A population-based cohort study.
    Proc Natl Acad Sci U S A. 2025;122:e2421513122.
    PubMed     Abstract available


  11. SCHNYDER SK, Molina JJ, Yamamoto R, Turner MS, et al
    Understanding Nash epidemics.
    Proc Natl Acad Sci U S A. 2025;122:e2409362122.
    PubMed     Abstract available


  12. ZHU Y, Cong Y, Sun Y, Sheng S, et al
    Molecular patterns of matrix protein 1 (M1): A strong predictor of adaptive evolution in H9N2 avian influenza viruses.
    Proc Natl Acad Sci U S A. 2025;122:e2423983122.
    PubMed     Abstract available


    February 2025
  13. GONZALES JE 2ND, Kim I, Bastiray A, Hwang W, et al
    Evolutionary rewiring of the dynamic network underpinning allosteric epistasis in NS1 of the influenza A virus.
    Proc Natl Acad Sci U S A. 2025;122:e2410813122.
    PubMed     Abstract available


  14. BRENNECKE B, Civili B, Sabale PM, Barluenga S, et al
    Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA-peptide conjugates.
    Proc Natl Acad Sci U S A. 2025;122:e2412850122.
    PubMed     Abstract available


  15. NGUYEN YTK, Zhu X, Han J, Rodriguez AJ, et al
    Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.
    Proc Natl Acad Sci U S A. 2025;122:e2416628122.
    PubMed     Abstract available


  16. LIAO Y, Ma H, Wang Z, Wang S, et al
    Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.
    Proc Natl Acad Sci U S A. 2025;122:e2406659122.
    PubMed     Abstract available


    January 2025
  17. DUCH RM, Loewen P, Robinson TS, Zakharov A, et al
    Governing in the face of a global crisis: When do voters punish and reward incumbent governments?
    Proc Natl Acad Sci U S A. 2025;122:e2405021122.
    PubMed     Abstract available


  18. KIRBY MB, Petersen BM, Faris JG, Kells SP, et al
    Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive.
    Proc Natl Acad Sci U S A. 2025;122:e2412787122.
    PubMed     Abstract available


  19. FERRERI LM, Seibert B, Caceres CJ, Patatanian K, et al
    Dispersal of influenza virus populations within the respiratory tract shapes their evolutionary potential.
    Proc Natl Acad Sci U S A. 2025;122:e2419985122.
    PubMed     Abstract available


  20. NAKAMURA S, Tanimura Y, Nomura R, Suzuki H, et al
    Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes.
    Proc Natl Acad Sci U S A. 2025;122:e2413465122.
    PubMed     Abstract available


  21. YAN S, Schlick T
    Heterogeneous and multiple conformational transition pathways between pseudoknots of the SARS-CoV-2 frameshift element.
    Proc Natl Acad Sci U S A. 2025;122:e2417479122.
    PubMed     Abstract available


  22. SCHULZ S, Tan TJC, Wu NC, Wang S, et al
    Epistatic hotspots organize antibody fitness landscape and boost evolvability.
    Proc Natl Acad Sci U S A. 2025;122:e2413884122.
    PubMed     Abstract available


  23. MAZIGI O, Langley DB, Henry JY, Burnett DL, et al
    Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2025;122:e2417544121.
    PubMed     Abstract available


  24. SINGH R, Im C, Qiu Y, Mackness B, et al
    Learning the language of antibody hypervariability.
    Proc Natl Acad Sci U S A. 2025;122:e2418918121.
    PubMed     Abstract available


    December 2024

  25. Correction for Rockey et al., Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.
    Proc Natl Acad Sci U S A. 2024;121:e2424158121.
    PubMed    


  26. GLAUBITZ A, Fu F
    Social dilemma of nonpharmaceutical interventions: Determinants of dynamic compliance and behavioral shifts.
    Proc Natl Acad Sci U S A. 2024;121:e2407308121.
    PubMed     Abstract available


  27. KLEIN EY, Impalli I, Poleon S, Denoel P, et al
    Global trends in antibiotic consumption during 2016-2023 and future projections through 2030.
    Proc Natl Acad Sci U S A. 2024;121:e2411919121.
    PubMed     Abstract available


  28. TOPPER MJ, Guarnieri JW, Haltom JA, Chadburn A, et al
    Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes.
    Proc Natl Acad Sci U S A. 2024;121:e2401968121.
    PubMed     Abstract available



  29. Correction for Shahriar et al., Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections.
    Proc Natl Acad Sci U S A. 2024;121:e2422717121.
    PubMed    


  30. ABT ER, Lam AK, Noguchi M, Rashid K, et al
    Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
    Proc Natl Acad Sci U S A. 2024;121:e2406332121.
    PubMed     Abstract available


    November 2024
  31. MEHMOOD S, Naseer S, Chen DL
    Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
    Proc Natl Acad Sci U S A. 2024;121:e2406034121.
    PubMed     Abstract available


  32. LIU L, Cui Z, Kunreuther H, Heal G, et al
    Modeling and testing strategic interdependence and tipping in public policy implementation.
    Proc Natl Acad Sci U S A. 2024;121:e2414041121.
    PubMed     Abstract available


  33. IYANIWURA SA, Ribeiro RM, Zitzmann C, Phan T, et al
    The kinetics of SARS-CoV-2 infection based on a human challenge study.
    Proc Natl Acad Sci U S A. 2024;121:e2406303121.
    PubMed     Abstract available


  34. NGUYEN MH, Palfy G, Fogeron ML, Ninot Pedrosa M, et al
    Analysis of the structure and interactions of the SARS-CoV-2 ORF7b accessory protein.
    Proc Natl Acad Sci U S A. 2024;121:e2407731121.
    PubMed     Abstract available


  35. ZHANG H, Wang Z, Nguyen HTT, Cornejo Pontelli M, et al
    Facilitating and restraining virus infection using cell-attachable soluble viral receptors.
    Proc Natl Acad Sci U S A. 2024;121:e2414583121.
    PubMed     Abstract available


  36. GARAIZAR A, Diaz-Oviedo D, Zablowsky N, Rissanen S, et al
    Toward understanding lipid reorganization in RNA lipid nanoparticles in acidic environments.
    Proc Natl Acad Sci U S A. 2024;121:e2404555121.
    PubMed     Abstract available


    October 2024
  37. WAN J, Wang C, Wang Z, Wang L, et al
    CXCL13 promotes broad immune responses induced by circular RNA vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2406434121.
    PubMed     Abstract available


  38. BAO L, Cao J, Gangadharan L, Huang D, et al
    Effects of lockdowns in shaping socioeconomic behaviors.
    Proc Natl Acad Sci U S A. 2024;121:e2405934121.
    PubMed     Abstract available


  39. BISHT P, Gallagher MD, Barrasa MI, Boucau J, et al
    Abortive infection of bat fibroblasts with SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2024;121:e2406773121.
    PubMed     Abstract available


  40. PAIARDI G, Ferraz M, Rusnati M, Wade RC, et al
    The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.
    Proc Natl Acad Sci U S A. 2024;121:e2404892121.
    PubMed     Abstract available


  41. KESSLER S, Stegen P, Zhan S, Schwemmle M, et al
    Jamaican fruit bats mount a stable and highly neutralizing antibody response after bat influenza virus infection.
    Proc Natl Acad Sci U S A. 2024;121:e2413619121.
    PubMed     Abstract available



  42. Editorial Expression of Concern: SARS-CoV-2 requires acidic pH to infect cells.
    Proc Natl Acad Sci U S A. 2024;121:e2417740121.
    PubMed    


  43. SHAHRIAR I, Kamra M, Kanduluru AK, Campbell CL, et al
    Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections.
    Proc Natl Acad Sci U S A. 2024;121:e2408469121.
    PubMed     Abstract available


  44. FITZGERALD J
    US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2403758121.
    PubMed    


  45. RAINS SA, Richards AS
    Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.
    Proc Natl Acad Sci U S A. 2024;121:e2409246121.
    PubMed    


  46. GAO M, Skolnick J
    Improved deep learning prediction of antigen-antibody interactions.
    Proc Natl Acad Sci U S A. 2024;121:e2410529121.
    PubMed     Abstract available


  47. DRAGOTAKES Q, Johnson PW, Buras MR, Carter RE, et al
    Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma.
    Proc Natl Acad Sci U S A. 2024;121:e2414957121.
    PubMed     Abstract available


  48. ASOR R, Olerinyova A, Burnap SA, Kushwah MS, et al
    Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
    Proc Natl Acad Sci U S A. 2024;121:e2403260121.
    PubMed     Abstract available


    September 2024
  49. ROWNTREE LC, Audsley J, Allen LF, McQuilten HA, et al
    SARS-CoV-2-specific CD8(+) T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years.
    Proc Natl Acad Sci U S A. 2024;121:e2411428121.
    PubMed     Abstract available


  50. CORRIGAN NM, Rokem A, Kuhl PK
    COVID-19 lockdown effects on adolescent brain structure suggest accelerated maturation that is more pronounced in females than in males.
    Proc Natl Acad Sci U S A. 2024;121:e2403200121.
    PubMed     Abstract available


  51. LOY CJ, Servellita V, Sotomayor-Gonzalez A, Bliss A, et al
    Plasma cell-free RNA signatures of inflammatory syndromes in children.
    Proc Natl Acad Sci U S A. 2024;121:e2403897121.
    PubMed     Abstract available


  52. HATTORI SI, Bulut H, Hayashi H, Kishimoto N, et al
    Structural and virologic mechanism of the emergence of resistance to M(pro) inhibitors in SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2024;121:e2404175121.
    PubMed     Abstract available


    August 2024
  53. ABBATE MF, Dupic T, Vigne E, Shahsavarian MA, et al
    Computational detection of antigen-specific B cell receptors following immunization.
    Proc Natl Acad Sci U S A. 2024;121:e2401058121.
    PubMed     Abstract available


  54. ILLIBAUER J, Clodi-Seitz T, Zoufaly A, Aberle JH, et al
    Diagnostic potential of blood plasma longitudinal viscosity measured using Brillouin light scattering.
    Proc Natl Acad Sci U S A. 2024;121:e2323016121.
    PubMed     Abstract available


  55. ROSS SL, Jiang S, Young MF, Meyer JL, et al
    In-person learning during the pandemic: Student take-up and school-level effects of remote and hybrid instruction on student outcomes.
    Proc Natl Acad Sci U S A. 2024;121:e2407322121.
    PubMed     Abstract available


  56. ROCKEY NC, Le Sage V, Shephard M, Vargas-Maldonado N, et al
    Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.
    Proc Natl Acad Sci U S A. 2024;121:e2322660121.
    PubMed     Abstract available


  57. ZHANG W, Shi K, Hsueh FC, Mendoza A, et al
    Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2322600121.
    PubMed     Abstract available


  58. MUHLEMANN B, Trimpert J, Walper F, Schmidt ML, et al
    Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.
    Proc Natl Acad Sci U S A. 2024;121:e2310917121.
    PubMed     Abstract available


    July 2024
  59. ROACH SN, Shepherd FK, Mickelson CK, Fiege JK, et al
    Tropism for ciliated cells is the dominant driver of influenza viral burst size in the human airway.
    Proc Natl Acad Sci U S A. 2024;121:e2320303121.
    PubMed     Abstract available


  60. GAGLIONE SA, Rosales TJ, Schmidt-Hong L, Baker BM, et al
    SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells.
    Proc Natl Acad Sci U S A. 2024;121:e2406615121.
    PubMed     Abstract available


  61. LEIBEL SL, McVicar RN, Murad R, Kwong EM, et al
    A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.
    Proc Natl Acad Sci U S A. 2024;121:e2408109121.
    PubMed     Abstract available


  62. GUARNIERI JW, Lie T, Albrecht YES, Hewin P, et al
    Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2321972121.
    PubMed     Abstract available


  63. FERRER-ORTA C, Vazquez-Monteagudo S, Ferrero DS, Martinez-Gonzalez B, et al
    Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2024;121:e2317977121.
    PubMed     Abstract available


  64. PERLMAN S
    A balance between innovation and biosafety.
    Proc Natl Acad Sci U S A. 2024;121:e2410451121.
    PubMed    


  65. HU Z, Lopez-Munoz AD, Kosik I, Li T, et al
    Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
    Proc Natl Acad Sci U S A. 2024;121:e2310421121.
    PubMed     Abstract available


  66. WU Q, Rafatian N, Wagner KT, Blamer J, et al
    SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.
    Proc Natl Acad Sci U S A. 2024;121:e2403581121.
    PubMed     Abstract available


  67. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
    Mortality risk information and health-seeking behavior during an epidemic.
    Proc Natl Acad Sci U S A. 2024;121:e2315677121.
    PubMed     Abstract available


  68. DE LA PRADA AG, Small ML
    How people are exposed to neighborhoods racially different from their own.
    Proc Natl Acad Sci U S A. 2024;121:e2401661121.
    PubMed     Abstract available


    June 2024
  69. KIM H, Park HH, Kim HN, Seo D, et al
    The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2319322121.
    PubMed     Abstract available


  70. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed     Abstract available


  71. GUILLEN JV, Glaunsinger BA
    SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.
    Proc Natl Acad Sci U S A. 2024;121:e2408794121.
    PubMed    


  72. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
    Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
    Proc Natl Acad Sci U S A. 2024;121:e2314262121.
    PubMed     Abstract available


  73. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed     Abstract available


  74. MCGOUGH L, Cobey S
    A speed limit on serial strain replacement from original antigenic sin.
    Proc Natl Acad Sci U S A. 2024;121:e2400202121.
    PubMed     Abstract available


  75. GUO YT, Jiang JB, Qiao GR, Luo RH, et al
    Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2321619121.
    PubMed     Abstract available


  76. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
    Biophysical principles predict fitness of SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2314518121.
    PubMed     Abstract available


  77. QU B, Miskey C, Gomer A, Kleinert RDV, et al
    TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Proc Natl Acad Sci U S A. 2024;121:e2407437121.
    PubMed     Abstract available


    May 2024
  78. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
    Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
    Proc Natl Acad Sci U S A. 2024;121:e2310677121.
    PubMed     Abstract available


  79. LICHAND G, Doria CA
    The lasting impacts of remote learning in the absence of remedial policies: Evidence from Brazil.
    Proc Natl Acad Sci U S A. 2024;121:e2316300121.
    PubMed     Abstract available


  80. LAL A, Thompson DM
    Did private election administration funding advantage Democrats in 2020?
    Proc Natl Acad Sci U S A. 2024;121:e2317563121.
    PubMed     Abstract available


  81. ENDEVELT K, Halperin E, Porat R
    Zoom out: An intervention on the virtual learning environment improves minority students' grades in two field experiments in Israel.
    Proc Natl Acad Sci U S A. 2024;121:e2313496121.
    PubMed     Abstract available


  82. MEI M, Cupic A, Miorin L, Ye C, et al
    Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2314166121.
    PubMed     Abstract available


  83. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
    Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2402540121.
    PubMed     Abstract available


  84. XIE Y, Yang F, Huang J, He Y, et al
    Declining Chinese attitudes toward the United States amid COVID-19.
    Proc Natl Acad Sci U S A. 2024;121:e2322920121.
    PubMed     Abstract available


  85. MORALES M, Yang MY, Goddard WA 3rd, Gray HB, et al
    Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1.
    Proc Natl Acad Sci U S A. 2024;121:e2402653121.
    PubMed     Abstract available


    April 2024
  86. MAO T, Kim J, Pena-Hernandez MA, Valle G, et al
    Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract.
    Proc Natl Acad Sci U S A. 2024;121:e2319566121.
    PubMed     Abstract available


  87. KUNG CSJ, Steptoe A
    Changes in well-being among socially isolated older people during the COVID-19 pandemic: An outcome-wide analysis.
    Proc Natl Acad Sci U S A. 2024;121:e2308697121.
    PubMed     Abstract available


  88. FREEDMAN AS, Sheen JK, Tsai S, Yao J, et al
    Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
    Proc Natl Acad Sci U S A. 2024;121:e2314357121.
    PubMed     Abstract available


  89. JOHANNESEN N, Tang-Andersen Martinello A, Meyer BB, Vestergaard ET, et al
    Substantial transmission of SARS-CoV-2 through casual contact in retail stores: Evidence from matched administrative microdata on card payments and testing.
    Proc Natl Acad Sci U S A. 2024;121:e2317589121.
    PubMed     Abstract available


  90. OTTER CJ, Bracci N, Parenti NA, Ye C, et al
    SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
    Proc Natl Acad Sci U S A. 2024;121:e2320194121.
    PubMed     Abstract available


  91. TAN TJC, Verma AK, Odle A, Lei R, et al
    Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike.
    Proc Natl Acad Sci U S A. 2024;121:e2317222121.
    PubMed     Abstract available


  92. BABOUN J, Beaudry IS, Castro LM, Gutierrez F, et al
    Identifying outbreaks in sewer networks: An adaptive sampling scheme under network's uncertainty.
    Proc Natl Acad Sci U S A. 2024;121:e2316616121.
    PubMed     Abstract available


    March 2024
  93. FLECKENSTEIN F, Stephan S, Hasse H
    Elucidating the behavior of the SARS-CoV-2 virus surface at vapor-liquid interfaces using molecular dynamics simulation.
    Proc Natl Acad Sci U S A. 2024;121:e2317194121.
    PubMed     Abstract available


  94. GAO R, Xu X, Kumar P, Liu Y, et al
    Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2310469121.
    PubMed     Abstract available


  95. CAHUANTZI R, Lythgoe KA, Hall I, Pellis L, et al
    Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods.
    Proc Natl Acad Sci U S A. 2024;121:e2317284121.
    PubMed     Abstract available


  96. DELGADO S, Somovilla P, Ferrer-Orta C, Martinez-Gonzalez B, et al
    Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.
    Proc Natl Acad Sci U S A. 2024;121:e2317851121.
    PubMed     Abstract available


  97. LIAO Z, Wang C, Tang X, Yang M, et al
    Human transferrin receptor can mediate SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2024;121:e2317026121.
    PubMed     Abstract available


  98. CHANG S, Shin KS, Park B, Park S, et al
    Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
    Proc Natl Acad Sci U S A. 2024;121:e2313681121.
    PubMed     Abstract available


  99. KRETSCH RC, Xu L, Zheludev IN, Zhou X, et al
    Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2320493121.
    PubMed     Abstract available


    February 2024
  100. RAINS SA, Richards AS
    US state vaccine mandates did not influence COVID-19 vaccination rates but reduced uptake of COVID-19 boosters and flu vaccines compared to bans on vaccine restrictions.
    Proc Natl Acad Sci U S A. 2024;121:e2313610121.
    PubMed     Abstract available


  101. ZHAO G, Xue L, Geisler HC, Xu J, et al
    Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery.
    Proc Natl Acad Sci U S A. 2024;121:e2314747121.
    PubMed     Abstract available


  102. ZHANG Y, Bharathi V, Dokoshi T, de Anda J, et al
    Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.
    Proc Natl Acad Sci U S A. 2024;121:e2300644120.
    PubMed     Abstract available


  103. PAGLINO E, Lundberg DJ, Wrigley-Field E, Zhou Z, et al
    Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths.
    Proc Natl Acad Sci U S A. 2024;121:e2313661121.
    PubMed     Abstract available


    January 2024
  104. MEYNIEL-SCHICKLIN L, Amaudrut J, Mallinjoud P, Guillier F, et al
    Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.
    Proc Natl Acad Sci U S A. 2024;121:e2308776121.
    PubMed     Abstract available


  105. PACIELLO I, Maccari G, Pantano E, Andreano E, et al
    High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2024;121:e2314730121.
    PubMed     Abstract available


  106. DEE TS
    Higher chronic absenteeism threatens academic recovery from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2312249121.
    PubMed     Abstract available


  107. GOTTLIEB A, Pham HPT, Saltarrelli JG, Lindsey JW, et al
    Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells.
    Proc Natl Acad Sci U S A. 2024;121:e2315857121.
    PubMed     Abstract available


  108. YU J, Zhao W, Chen X, Lu H, et al
    A plant virus manipulates the long-winged morph of insect vectors.
    Proc Natl Acad Sci U S A. 2024;121:e2315341121.
    PubMed     Abstract available


  109. BAUM MY, Jacob BA
    Racial differences in parent response to COVID schooling policies.
    Proc Natl Acad Sci U S A. 2024;121:e2307308120.
    PubMed     Abstract available


  110. DIDIER G, Glatt-Holtz NE, Holbrook AJ, Magee AF, et al
    On the surprising effectiveness of a simple matrix exponential derivative approximation, with application to global SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2024;121:e2318989121.
    PubMed     Abstract available


  111. VAUGHAN TG, Scire J, Nadeau SA, Stadler T, et al
    Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data.
    Proc Natl Acad Sci U S A. 2024;121:e2308125121.
    PubMed     Abstract available


  112. FINNEY J, Moseman AP, Kong S, Watanabe A, et al
    Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.
    Proc Natl Acad Sci U S A. 2024;121:e2316964120.
    PubMed     Abstract available


  113. CHEN Y, Gel YR, Marathe MV, Poor HV, et al
    A simplicial epidemic model for COVID-19 spread analysis.
    Proc Natl Acad Sci U S A. 2024;121:e2313171120.
    PubMed     Abstract available


    December 2023
  114. RAO X, Zhao R, Tong Z, Guo S, et al
    Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2314193120.
    PubMed     Abstract available


  115. YE Z, Bonam SR, McKay LGA, Plante JA, et al
    Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants.
    Proc Natl Acad Sci U S A. 2023;120:e2311752120.
    PubMed     Abstract available


  116. MIYAMOTO S, Nishiyama T, Ueno A, Park H, et al
    Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2314808120.
    PubMed     Abstract available


  117. STUMPFF JP 2ND, Kim SY, McFadden MI, Nishida A, et al
    Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes.
    Proc Natl Acad Sci U S A. 2023;120:e2300474120.
    PubMed     Abstract available


  118. NAPOLI L, Sekara V, Garcia-Herranz M, Karsai M, et al
    Socioeconomic reorganization of communication and mobility networks in response to external shocks.
    Proc Natl Acad Sci U S A. 2023;120:e2305285120.
    PubMed     Abstract available


  119. ZHANG H, Wang Z, Nguyen HTT, Watson AJ, et al
    Integrin alpha(5)beta(1) contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction.
    Proc Natl Acad Sci U S A. 2023;120:e2311913120.
    PubMed     Abstract available


  120. IOANNIDIS JPA, Zonta F, Levitt M
    Variability in excess deaths across countries with different vulnerability during 2020-2023.
    Proc Natl Acad Sci U S A. 2023;120:e2309557120.
    PubMed     Abstract available


  121. TURNER CA, Khalil H, Murphy-Weinberg V, Hagenauer MH, et al
    The impact of COVID-19 on a college freshman sample reveals genetic and nongenetic forms of susceptibility and resilience to stress.
    Proc Natl Acad Sci U S A. 2023;120:e2305779120.
    PubMed     Abstract available


  122. TORCHE F, Nobles J
    Vaccination, immunity, and the changing impact of COVID-19 on infant health.
    Proc Natl Acad Sci U S A. 2023;120:e2311573120.
    PubMed     Abstract available


  123. CHENG CW, Wu CY, Wang SW, Chen JY, et al
    Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).
    Proc Natl Acad Sci U S A. 2023;120:e2314392120.
    PubMed     Abstract available


    November 2023
  124. ESPINOZA B, Adiga A, Venkatramanan S, Warren AS, et al
    Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions.
    Proc Natl Acad Sci U S A. 2023;120:e2305227120.
    PubMed     Abstract available


  125. CONDOR CAPCHA JM, Kamiar A, Robleto E, Saad AG, et al
    Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
    Proc Natl Acad Sci U S A. 2023;120:e2308342120.
    PubMed     Abstract available


  126. CHEN Y, Lei X, Jiang Z, Humphries F, et al
    Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
    Proc Natl Acad Sci U S A. 2023;120:e2308355120.
    PubMed     Abstract available


  127. ALTMEJD A, Ostergren O, Bjorkegren E, Persson T, et al
    Inequality and COVID-19 in Sweden: Relative risks of nine bad life events, by four social gradients, in pandemic vs. prepandemic years.
    Proc Natl Acad Sci U S A. 2023;120:e2303640120.
    PubMed     Abstract available


  128. PETRONE ME, Parry R, Mifsud JCO, Van Brussel K, et al
    Evidence for an ancient aquatic origin of the RNA viral order Articulavirales.
    Proc Natl Acad Sci U S A. 2023;120:e2310529120.
    PubMed     Abstract available


  129. ZHOU J, Sukhova K, Peacock TP, McKay PF, et al
    Omicron breakthrough infections in vaccinated or previously infected hamsters.
    Proc Natl Acad Sci U S A. 2023;120:e2308655120.
    PubMed     Abstract available


    October 2023
  130. EDGAR JE, Trezise S, Anthony RM, Krammer F, et al
    Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgammaR-dependent protection in vivo.
    Proc Natl Acad Sci U S A. 2023;120:e2314905120.
    PubMed     Abstract available


  131. CHARDES V, Mazzolini A, Mora T, Walczak AM, et al
    Evolutionary stability of antigenically escaping viruses.
    Proc Natl Acad Sci U S A. 2023;120:e2307712120.
    PubMed     Abstract available


  132. FISCHER H, Huff M, Anders G, Said N, et al
    Metacognition, public health compliance, and vaccination willingness.
    Proc Natl Acad Sci U S A. 2023;120:e2105425120.
    PubMed     Abstract available


  133. WISSLER A, DeWitte SN
    Frailty and survival in the 1918 influenza pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2304545120.
    PubMed     Abstract available


  134. ZHANG J, Tan S, Peng C, Xu X, et al
    Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai.
    Proc Natl Acad Sci U S A. 2023;120:e2306710120.
    PubMed     Abstract available


  135. HART WS, Park H, Jeong YD, Kim KS, et al
    Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study.
    Proc Natl Acad Sci U S A. 2023;120:e2305451120.
    PubMed     Abstract available


  136. SCHLUTER M, Brelsford C, Ferraro PJ, Orach K, et al
    Unraveling complex causal processes that affect sustainability requires more integration between empirical and modeling approaches.
    Proc Natl Acad Sci U S A. 2023;120:e2215676120.
    PubMed     Abstract available


  137. ZHAO P, Liu Q, Ma T, Kang T, et al
    Policy instruments facilitate China's COVID-19 work resumption.
    Proc Natl Acad Sci U S A. 2023;120:e2305692120.
    PubMed     Abstract available


  138. XU J, Zhang Y, Qu P, Shamseldin MM, et al
    A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
    Proc Natl Acad Sci U S A. 2023;120:e2220403120.
    PubMed     Abstract available


    September 2023
  139. HUANG R, Warner Jenkins G, Kim Y, Stanfield RL, et al
    The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2303455120.
    PubMed     Abstract available


  140. TAO Y, Yang L, Jaffe S, Amini F, et al
    Climate mitigation potentials of teleworking are sensitive to changes in lifestyle and workplace rather than ICT usage.
    Proc Natl Acad Sci U S A. 2023;120:e2304099120.
    PubMed     Abstract available


  141. GUSEMAN AJ, Rennick LJ, Nambulli S, Roy CN, et al
    Targeting spike glycans to inhibit SARS-CoV2 viral entry.
    Proc Natl Acad Sci U S A. 2023;120:e2301518120.
    PubMed     Abstract available


  142. XU H, Zhong Y, Yang J, Fu L, et al
    Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2023;120:e2309870120.
    PubMed    


  143. YAN H, Zhang R, Liu X, Wang Y, et al
    Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease.
    Proc Natl Acad Sci U S A. 2023;120:e2309289120.
    PubMed    


    August 2023
  144. ZHANG Q
    Complex Interplay between Population Immunity and Viral Dynamics.
    Proc Natl Acad Sci U S A. 2023;120:e2312198120.
    PubMed    


  145. ALHAMMAD YM, Parthasarathy S, Ghimire R, Kerr CM, et al
    SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.
    Proc Natl Acad Sci U S A. 2023;120:e2302083120.
    PubMed     Abstract available


  146. CIROVIC A, Cirovic A
    Could iron deficiency potentiate the appearance of complications in Influenza A virus infection?
    Proc Natl Acad Sci U S A. 2023;120:e2311262120.
    PubMed    


  147. BOLTON MJ, Santos JJS, Arevalo CP, Griesman T, et al
    IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.
    Proc Natl Acad Sci U S A. 2023;120:e2216521120.
    PubMed     Abstract available


  148. RAO Z, Brunner E, Giszas B, Iyer-Bierhoff A, et al
    Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.
    Proc Natl Acad Sci U S A. 2023;120:e2302070120.
    PubMed     Abstract available


  149. BAILEY MJ, Currie J, Schwandt H
    The COVID-19 baby bump in the United States.
    Proc Natl Acad Sci U S A. 2023;120:e2222075120.
    PubMed     Abstract available


  150. STAQUICINI DI, Cardo-Vila M, Rotolo JA, Staquicini FI, et al
    Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
    Proc Natl Acad Sci U S A. 2023;120:e2220269120.
    PubMed     Abstract available


  151. WANG PY, Ma J, Kim YC, Son AY, et al
    WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.
    Proc Natl Acad Sci U S A. 2023;120:e2302738120.
    PubMed     Abstract available


  152. MANRUBIA S, Cuesta JA
    Physics of diffusion in viral genome evolution.
    Proc Natl Acad Sci U S A. 2023;120:e2310999120.
    PubMed    


  153. MAIO N, Raza MK, Li Y, Zhang DL, et al
    An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase modulates its RNA-binding and -unwinding activities.
    Proc Natl Acad Sci U S A. 2023;120:e2303860120.
    PubMed     Abstract available


  154. ZELLER MA, Ma J, Wong FY, Tum S, et al
    The genomic landscape of swine influenza A viruses in Southeast Asia.
    Proc Natl Acad Sci U S A. 2023;120:e2301926120.
    PubMed     Abstract available


  155. YANG L, Wang Z, Wang L, Vrancken B, et al
    Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2305403120.
    PubMed     Abstract available


  156. TSANG TK, Wang C, Fang VJ, Perera RAPM, et al
    Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infections.
    Proc Natl Acad Sci U S A. 2023;120:e2304750120.
    PubMed     Abstract available


  157. SHEPHERD SJ, Han X, Mukalel AJ, El-Mayta R, et al
    Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.
    Proc Natl Acad Sci U S A. 2023;120:e2303567120.
    PubMed     Abstract available


  158. BILINSKI AM, Salomon JA, Hatfield LA
    Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations.
    Proc Natl Acad Sci U S A. 2023;120:e2302528120.
    PubMed     Abstract available


  159. BADER SM, Cooney JP, Sheerin D, Taiaroa G, et al
    SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.
    Proc Natl Acad Sci U S A. 2023;120:e2301689120.
    PubMed     Abstract available


  160. LIU M, Bakker AS, Narimatsu Y, van Kuppeveld FJM, et al
    H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2304992120.
    PubMed     Abstract available


  161. KESHAVIAH A, Huff I, Hu XC, Guidry V, et al
    Separating signal from noise in wastewater data: An algorithm to identify community-level COVID-19 surges in real time.
    Proc Natl Acad Sci U S A. 2023;120:e2216021120.
    PubMed     Abstract available


  162. CHANG TY, Jacobson M, Shah M, Kopetsky M, et al
    Reminders, but not monetary incentives, increase COVID-19 booster uptake.
    Proc Natl Acad Sci U S A. 2023;120:e2302725120.
    PubMed     Abstract available


  163. LI P, Xue B, Schnicker NJ, Wong LR, et al
    Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence.
    Proc Natl Acad Sci U S A. 2023;120:e2305674120.
    PubMed     Abstract available


  164. CHAN JCK, Ahn D
    Unproctored online exams provide meaningful assessment of student learning.
    Proc Natl Acad Sci U S A. 2023;120:e2302020120.
    PubMed     Abstract available


    July 2023
  165. ALTANGEREL N, Neuman BW, Hemmer PR, Yakovlev VV, et al
    Label-free drug interaction screening via Raman microscopy.
    Proc Natl Acad Sci U S A. 2023;120:e2218826120.
    PubMed     Abstract available


  166. QIAO Y, Wotring JW, Zheng Y, Zhang CJ, et al
    Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
    Proc Natl Acad Sci U S A. 2023;120:e2221809120.
    PubMed     Abstract available


  167. GOIRIZ L, Ruiz R, Garibo-I-Orts O, Conejero JA, et al
    A variant-dependent molecular clock with anomalous diffusion models SARS-CoV-2 evolution in humans.
    Proc Natl Acad Sci U S A. 2023;120:e2303578120.
    PubMed     Abstract available


  168. ASANOV I, Asanov AM, Astebro T, Buenstorf G, et al
    System-, teacher-, and student-level interventions for improving participation in online learning at scale in high schools.
    Proc Natl Acad Sci U S A. 2023;120:e2216686120.
    PubMed     Abstract available


  169. ZHANG P, Falcone S, Tsybovsky Y, Singh M, et al
    Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles.
    Proc Natl Acad Sci U S A. 2023;120:e2305896120.
    PubMed     Abstract available


  170. PRASAD PV, Steele MK, Reed C, Meyers LA, et al
    Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.
    Proc Natl Acad Sci U S A. 2023;120:e2300590120.
    PubMed     Abstract available


  171. LOPEZ-MUNOZ AD, Santos JJS, Yewdell JW
    Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy.
    Proc Natl Acad Sci U S A. 2023;120:e2304087120.
    PubMed     Abstract available


    June 2023
  172. JONES NM, Thompson RR, Holman EA, Silver RC, et al
    Idiosyncratic media exposures during a pandemic and their link to well-being, cognition, and behavior over time.
    Proc Natl Acad Sci U S A. 2023;120:e2304550120.
    PubMed     Abstract available


  173. THIJSSEN V, Hurdiss DL, Debski-Antoniak OJ, Spence MA, et al
    A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein.
    Proc Natl Acad Sci U S A. 2023;120:e2303292120.
    PubMed     Abstract available


  174. LIU K, Tang M, Xu W, Meng X, et al
    An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo.
    Proc Natl Acad Sci U S A. 2023;120:e2207210120.
    PubMed     Abstract available


  175. TRAULSEN A, Levin SA, Saad-Roy CM
    Individual costs and societal benefits of interventions during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2303546120.
    PubMed     Abstract available


  176. MISSON MINDREBO L, Liu H, Ozorowski G, Tran Q, et al
    Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
    Proc Natl Acad Sci U S A. 2023;120:e2216612120.
    PubMed     Abstract available


  177. SOOD M, Sridhar A, Eletreby R, Wu CW, et al
    Spreading processes with mutations over multilayer networks.
    Proc Natl Acad Sci U S A. 2023;120:e2302245120.
    PubMed     Abstract available


  178. GUENTHOER J, Lilly M, Starr TN, Dadonaite B, et al
    Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
    Proc Natl Acad Sci U S A. 2023;120:e2220948120.
    PubMed     Abstract available


  179. TADA T, Minnee J, Landau NR
    Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model.
    Proc Natl Acad Sci U S A. 2023;120:e2303509120.
    PubMed     Abstract available


    May 2023
  180. PETERSEN M, Nagele FL, Mayer C, Schell M, et al
    Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2217232120.
    PubMed     Abstract available


  181. PANDEY JP
    Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs.
    Proc Natl Acad Sci U S A. 2023;120:e2306078120.
    PubMed    


  182. PARK SW, Sun K, Abbott S, Sender R, et al
    Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2221887120.
    PubMed     Abstract available


  183. HOSOYA T, Oba S, Komiya Y, Kawata D, et al
    Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2300155120.
    PubMed     Abstract available


  184. SCHUMM B, Bremer S, Knodlseder K, Schonfelder M, et al
    Lung aerosol particle emission increases with age at rest and during exercise.
    Proc Natl Acad Sci U S A. 2023;120:e2301145120.
    PubMed     Abstract available


  185. MAZEL-SANCHEZ B, Niu C, Williams N, Bachmann M, et al
    Influenza A virus exploits transferrin receptor recycling to enter host cells.
    Proc Natl Acad Sci U S A. 2023;120:e2214936120.
    PubMed     Abstract available


  186. BARRETO EA, Cruz AS, Veras FP, Martins R, et al
    COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis.
    Proc Natl Acad Sci U S A. 2023;120:e2217119120.
    PubMed     Abstract available


  187. TREVISIN C, Bertuzzo E, Pasetto D, Mari L, et al
    Spatially explicit effective reproduction numbers from incidence and mobility data.
    Proc Natl Acad Sci U S A. 2023;120:e2219816120.
    PubMed     Abstract available


  188. HARTON M, Kinzy TG, Bear A
    Monitoring and addressing the long-term impacts of the COVID-19 pandemic on women in academic science, engineering, and medicine.
    Proc Natl Acad Sci U S A. 2023;120:e2304603120.
    PubMed    


  189. EASTERLIN RA, O'Connor KJ
    Three years of COVID-19 and life satisfaction in Europe: A macro view.
    Proc Natl Acad Sci U S A. 2023;120:e2300717120.
    PubMed     Abstract available


  190. SHEA K, Borchering RK, Probert WJM, Howerton E, et al
    Multiple models for outbreak decision support in the face of uncertainty.
    Proc Natl Acad Sci U S A. 2023;120:e2207537120.
    PubMed     Abstract available


  191. SONG Y, Yao H, Wu N, Xu J, et al
    In situ architecture and membrane fusion of SARS-CoV-2 Delta variant.
    Proc Natl Acad Sci U S A. 2023;120:e2213332120.
    PubMed     Abstract available


  192. EINAV L, Finkelstein A
    The risk of losing health insurance in the United States is large, and remained so after the Affordable Care Act.
    Proc Natl Acad Sci U S A. 2023;120:e2222100120.
    PubMed     Abstract available


  193. XU H, Li S, Liu J, Cheng J, et al
    Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2301775120.
    PubMed     Abstract available


    April 2023
  194. LI C, Huang J, Yu Y, Wan Z, et al
    Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
    Proc Natl Acad Sci U S A. 2023;120:e2300376120.
    PubMed     Abstract available


  195. ZHANG J, Yang W, Roy S, Liu H, et al
    Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission.
    Proc Natl Acad Sci U S A. 2023;120:e2218623120.
    PubMed     Abstract available


  196. GUINAT C, Tang H, Yang Q, Valenzuela Agui C, et al
    Bayesian phylodynamics reveals the transmission dynamics of avian influenza A(H7N9) virus at the human-live bird market interface in China.
    Proc Natl Acad Sci U S A. 2023;120:e2215610120.
    PubMed     Abstract available


  197. LEE CY, Raghunathan V, Caceres CJ, Geiger G, et al
    Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies.
    Proc Natl Acad Sci U S A. 2023;120:e2208718120.
    PubMed     Abstract available


  198. MORIYAMA M, Lucas C, Monteiro VS, Iwasaki A, et al
    Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.
    Proc Natl Acad Sci U S A. 2023;120:e2221652120.
    PubMed     Abstract available


  199. PIZZIOL V, Demaj X, Di Paolo R, Capraro V, et al
    Political ideology and generosity around the globe.
    Proc Natl Acad Sci U S A. 2023;120:e2219676120.
    PubMed     Abstract available


  200. IZADI A, Hailu A, Godzwon M, Wrighton S, et al
    Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization.
    Proc Natl Acad Sci U S A. 2023;120:e2217590120.
    PubMed     Abstract available


  201. OTTER CJ, Fausto A, Tan LH, Khosla AS, et al
    Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
    Proc Natl Acad Sci U S A. 2023;120:e2218083120.
    PubMed     Abstract available


    March 2023
  202. ARPINO B, Bordone V, Di Gessa G
    COVID-19 precautionary behaviors and vaccine acceptance among older individuals: The role of close kin.
    Proc Natl Acad Sci U S A. 2023;120:e2214382120.
    PubMed     Abstract available


  203. YANG K, Wang C, Kreutzberger AJB, White KI, et al
    Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor.
    Proc Natl Acad Sci U S A. 2023;120:e2300360120.
    PubMed     Abstract available


  204. HUMBERT M, Olofsson A, Wullimann D, Niessl J, et al
    Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age.
    Proc Natl Acad Sci U S A. 2023;120:e2220320120.
    PubMed     Abstract available


  205. KIM Y, Ryu JY, Kim HU, Lee SY, et al
    Computational prediction of interactions between Paxlovid and prescription drugs.
    Proc Natl Acad Sci U S A. 2023;120:e2221857120.
    PubMed     Abstract available


  206. G MOREIRA T, Gauthier CD, Murphy L, Lanser TB, et al
    Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19.
    Proc Natl Acad Sci U S A. 2023;120:e2220272120.
    PubMed     Abstract available


  207. SAAR KL, McCorkindale W, Fearon D, Boby M, et al
    Turning high-throughput structural biology into predictive inhibitor design.
    Proc Natl Acad Sci U S A. 2023;120:e2214168120.
    PubMed     Abstract available


  208. LIU Z, Zhou J, Wang X, Xu W, et al
    A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
    Proc Natl Acad Sci U S A. 2023;120:e2221713120.
    PubMed     Abstract available


  209. HARIHARAN VN, Shin M, Chang CW, O'Reilly D, et al
    Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2023;120:e2219523120.
    PubMed     Abstract available


  210. MUNOZ-BASAGOITI J, Monteiro FLL, Krumpe LRH, Armario-Najera V, et al
    Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2023;120:e2214561120.
    PubMed     Abstract available


  211. STENSETH NC, Schlatte R, Liu X, Pielke R Jr, et al
    How to avoid a local epidemic becoming a global pandemic.
    Proc Natl Acad Sci U S A. 2023;120:e2220080120.
    PubMed     Abstract available


  212. CUI L, Fang Z, De Souza CM, Lerbs T, et al
    Innate immune cell activation causes lung fibrosis in a humanized model of long COVID.
    Proc Natl Acad Sci U S A. 2023;120:e2217199120.
    PubMed     Abstract available


  213. HE D, Lin L, Artzy-Randrup Y, Demirhan H, et al
    Resolving the enigma of Iquitos and Manaus: A modeling analysis of multiple COVID-19 epidemic waves in two Amazonian cities.
    Proc Natl Acad Sci U S A. 2023;120:e2211422120.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.